Getz K - Search Results

1

Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.

Singh RK, Getz KR, Kyeyune JK, Jeon MS, Luo C, Luo J, Toriola AT. Singh RK, et al. Among authors: getz kr. Cancer Epidemiol Biomarkers Prev. 2024 May 3. doi: 10.1158/1055-9965.EPI-24-0017. Online ahead of print. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38700429

2

Correction: Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials.

Dirks A, Florez M, Torche F, Young S, Slizgi B, Getz K. Dirks A, et al. Among authors: getz k. Ther Innov Regul Sci. 2024 Apr 30. doi: 10.1007/s43441-024-00648-z. Online ahead of print. Ther Innov Regul Sci. 2024. PMID: 38689158 No abstract available.

3

Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.

Newman H, Li Y, Huang YV, Elgarten CW, Myers RM, Ruiz J, Zheng DJ, Leahy AB, Aftandilian C, Arnold SD, Bona K, Gramatges MM, Heneghan MB, Maloney KW, Modi AJ, Mody RJ, Morgan E, Rubnitz J, Winick N, Wilkes JJ, Seif AE, Fisher BT, Aplenc R, Getz KD. Newman H, et al. Among authors: getz kd. Cancer Med. 2024 Apr;13(7):e6966. doi: 10.1002/cam4.6966. Cancer Med. 2024. PMID: 38572962 Free PMC article.

4

Benchmarking Site Activation and Patient Enrollment.

Lamberti MJ, Dirks A, Kikuchi N, Patel Cervantes N, Getz K. Lamberti MJ, et al. Among authors: getz k. Ther Innov Regul Sci. 2024 Apr 3. doi: 10.1007/s43441-024-00638-1. Online ahead of print. Ther Innov Regul Sci. 2024. PMID: 38568347

5

New Benchmarks on Protocol Amendment Experience in Oncology Clinical Trials.

Botto E, Smith Z, Getz K. Botto E, et al. Among authors: getz k. Ther Innov Regul Sci. 2024 Mar 26. doi: 10.1007/s43441-024-00629-2. Online ahead of print. Ther Innov Regul Sci. 2024. PMID: 38530628

6

New Benchmarks on Protocol Amendment Practices, Trends and their Impact on Clinical Trial Performance.

Getz K, Smith Z, Botto E, Murphy E, Dauchy A. Getz K, et al. Ther Innov Regul Sci. 2024 May;58(3):539-548. doi: 10.1007/s43441-024-00622-9. Epub 2024 Mar 4. Ther Innov Regul Sci. 2024. PMID: 38438658

7

Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials.

Dirks A, Florez M, Torche F, Young S, Slizgi B, Getz K. Dirks A, et al. Among authors: getz k. Ther Innov Regul Sci. 2024 May;58(3):520-527. doi: 10.1007/s43441-024-00618-5. Epub 2024 Feb 16. Ther Innov Regul Sci. 2024. PMID: 38366107 Free PMC article.

8

Bayesian semiparametric model for sequential treatment decisions with informative timing.

Oganisian A, Getz KD, Alonzo TA, Aplenc R, Roy JA. Oganisian A, et al. Among authors: getz kd. Biostatistics. 2024 Jan 16:kxad035. doi: 10.1093/biostatistics/kxad035. Online ahead of print. Biostatistics. 2024. PMID: 38230584

9

Quantifying Site Burden to Optimize Protocol Performance.

Florez M, Smith Z, Olah Z, Martin M, Getz K. Florez M, et al. Among authors: getz k. Ther Innov Regul Sci. 2024 Mar;58(2):347-356. doi: 10.1007/s43441-023-00602-5. Epub 2024 Jan 8. Ther Innov Regul Sci. 2024. PMID: 38191957

10

Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data.

Cao L, Huang YS, Getz KD, Seif AE, Ruiz J, Miller TP, Fisher BT, Aplenc R, Li Y. Cao L, et al. Among authors: getz kd. Pediatr Blood Cancer. 2024 Mar;71(3):e30858. doi: 10.1002/pbc.30858. Epub 2024 Jan 8. Pediatr Blood Cancer. 2024. PMID: 38189744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page